anti-guanylyl cyclase C CAR-T cell therapy (Legend Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-guanylyl cyclase C CAR-T cell therapy (Legend Biotech)
Drug Alias NameLCAR-G08T
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionHeat-stable enterotoxin receptor modulators
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLegend Biotech Corp
China Registration ClassN/A

Develop Information

Active CompaniesLegend Biotech Corp
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A